Transfusion-related acute lung injury: a clinical review

[1]  L. Kovacs,et al.  Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. , 2012, JAMA.

[2]  M. Levi,et al.  Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: A prospective nested case-control study* , 2012, Critical care medicine.

[3]  R. Weiskopf,et al.  Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit , 2012, Critical care medicine.

[4]  Z. Werb,et al.  Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. , 2012, The Journal of clinical investigation.

[5]  C. Silliman,et al.  Therapeutic options for transfusion related acute lung injury; the potential of the G2A receptor. , 2012, Current pharmaceutical design.

[6]  R. Lutter,et al.  Mechanical Ventilation and the Titer of Antibodies as Risk Factors for the Development of Transfusion-Related Lung Injury , 2012, Critical care research and practice.

[7]  Yulia Lin,et al.  Transfusion‐related acute lung injury prevention measures and their impact at Canadian Blood Services , 2012, Transfusion.

[8]  E. Beckers,et al.  Storage time of blood products and transfusion‐related acute lung injury , 2012, Transfusion.

[9]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[10]  J. Hartwig,et al.  Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. , 2011, Blood.

[11]  E. Brojer,et al.  Lysophosphatidylcholines: Bioactive Lipids Generated During Storage of Blood Components , 2012, Archivum Immunologiae et Therapiae Experimentalis.

[12]  R. Nieuwland,et al.  Accumulation of bioactive lipids during storage of blood products is not cell but plasma derived and temperature dependent , 2011, Transfusion.

[13]  T. McMahon,et al.  Impaired adenosine-5′-triphosphate release from red blood cells promotes their adhesion to endothelial cells: A mechanism of hypoxemia after transfusion* , 2011, Critical care medicine.

[14]  E. Beckers,et al.  Male‐only fresh‐frozen plasma for transfusion‐related acute lung injury prevention: before‐and‐after comparative cohort study , 2011, Transfusion.

[15]  Marcus J Schultz,et al.  The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. , 2011, Blood.

[16]  H. Vrielink,et al.  Prevalence of leucocyte antibodies in the Dutch donor population , 2011, Vox sanguinis.

[17]  R. Bohle,et al.  Mechanism of transfusion-related acute lung injury induced by HLA class II antibodies. , 2009, Blood.

[18]  H. van Lenthe,et al.  Supernatant of stored platelets causes lung inflammation and coagulopathy in a novel in vivo transfusion model. , 2010, Blood.

[19]  R. Benjamin,et al.  Effective reduction of transfusion‐related acute lung injury risk with male‐predominant plasma strategy in the American Red Cross (2006‐2008) , 2010, Transfusion.

[20]  K. McFann,et al.  Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding , 2010, Intensive Care Medicine.

[21]  M. Kersten,et al.  The divergent clinical presentations of transfusion-related acute lung injury illustrated by two case reports. , 2010, Medical science monitor : international medical journal of experimental and clinical research.

[22]  C. Hillyer,et al.  Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors , 2010, Transfusion.

[23]  R. Lutter,et al.  Mechanical ventilation aggravates transfusion-related acute lung injury induced by MHC-I class antibodies , 2010, Intensive Care Medicine.

[24]  J. Binnekade,et al.  Risk factors and outcome of transfusion-related acute lung injury in the critically ill: A nested case–control study* , 2010, Critical care medicine.

[25]  O. Gajic,et al.  The practice of reporting transfusion‐related acute lung injury: a national survey among clinical and preclinical disciplines , 2010, Transfusion.

[26]  M. Matthay,et al.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. , 2009, The Journal of clinical investigation.

[27]  Y. Yatomi,et al.  Impact of fresh‐frozen plasma from male‐only donors versus mixed‐sex donors on postoperative respiratory function in surgical patients: a prospective case‐controlled study , 2009, Transfusion.

[28]  M. Schultz,et al.  Transfusion-related acute lung injury: a change of perspective. , 2009, The Netherlands journal of medicine.

[29]  J. Römisch,et al.  Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)‐treated plasma OctaplasLG® , 2009, Vox sanguinis.

[30]  C. Hillyer,et al.  The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion‐related acute lung injury risk reduction strategy , 2009, Transfusion.

[31]  E. Moore,et al.  Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. , 2009, Blood.

[32]  Janet S. Lee,et al.  Loss of red cell chemokine scavenging promotes transfusion-related lung inflammation. , 2009, Blood.

[33]  O. Gajic,et al.  The accuracy of natriuretic peptides (brain natriuretic peptide and N‐terminal pro‐brain natriuretic) in the differentiation between transfusion‐related acute lung injury and transfusion‐related circulatory overload in the critically ill , 2009, Transfusion.

[34]  J. Binnekade,et al.  Preventing TRALI: ladies first, what follows? , 2008, Critical care medicine.

[35]  P. Marik,et al.  Acute lung injury following blood transfusion: Expanding the definition , 2008, Critical care medicine.

[36]  C. Chapman,et al.  How much residual plasma may cause TRALI? , 2008, Transfusion medicine.

[37]  F. Szabó,et al.  Use of fresh‐frozen plasma at Royal Darwin Hospital: a retrospective audit , 2008, Internal medicine journal.

[38]  P. Marik,et al.  Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature* , 2008, Critical care medicine.

[39]  M. Schultz,et al.  [Transfusion-related acute lung injury (TRALI) in the Netherlands in 2002-2005]. , 2008, Nederlands tijdschrift voor geneeskunde.

[40]  A. Leaver,et al.  Acute lung injury after ruptured abdominal aortic aneurysm repair: The effect of excluding donations from females from the production of fresh frozen plasma* , 2008, Critical care medicine.

[41]  S. Dzik,et al.  A touch of TRALI , 2008, Transfusion.

[42]  M. R. Schipperus,et al.  Transfusiegerelateerde acute longbeschadiging (TRALI) in Nederland in 2002-2005 , 2008 .

[43]  M. Malinchoc,et al.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. , 2007, American journal of respiratory and critical care medicine.

[44]  M. Keegan,et al.  Toward the prevention of acute lung injury: Protocol-guided limitation of large tidal volume ventilation and inappropriate transfusion* , 2007, Critical care medicine.

[45]  O. Flesland.  A comparison of complication rates based on published haemovigilance data , 2007, Intensive Care Medicine.

[46]  O. Gajic,et al.  Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. , 2007, Chest.

[47]  R. Benjamin,et al.  Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross , 2007, Transfusion.

[48]  D. Stroncek,et al.  The transfusion of neutrophil‐specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions , 2007, Transfusion.

[49]  U. Sachs,et al.  The pathogenesis of transfusion‐related acute lung injury (TRALI) , 2007, British journal of haematology.

[50]  H. Cohen,et al.  Serious hazards of transfusion: a decade of hemovigilance in the UK. , 2006, Transfusion medicine reviews.

[51]  C. Silliman,et al.  Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. , 2006, Blood.

[52]  Gordon R Bernard,et al.  Comparison of two fluid-management strategies in acute lung injury. , 2006, The New England journal of medicine.

[53]  S. Kleinman.  A perspective on transfusion‐related acute lung injury two years after the Canadian Consensus Conference , 2006, Transfusion.

[54]  T. Lesnick,et al.  Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study , 2006, Transfusion.

[55]  M. Matthay,et al.  Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. , 2006, The Journal of clinical investigation.

[56]  C. Silliman.  The two-event model of transfusion-related acute lung injury , 2006, Critical care medicine.

[57]  J. Mcfarland,et al.  Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies. , 2006, Critical care medicine.

[58]  J. Vincent,et al.  Transfusion in the intensive care unit , 2006, Critical care medicine.

[59]  O. Gajic,et al.  Pulmonary edema after transfusion: How to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury , 2006, Critical care medicine.

[60]  S. Moore,et al.  Transfusion-related acute lung injury (TRALI): clinical presentation, treatment, and prognosis. , 2006, Critical care medicine.

[61]  E. Ogier-Denis,et al.  Interleukin-8-induced Priming of Neutrophil Oxidative Burst Requires Sequential Recruitment of NADPH Oxidase Components into Lipid Rafts* , 2005, Journal of Biological Chemistry.

[62]  G. Bein,et al.  White blood cell–reactive antibodies are undetectable in solvent/detergent plasma , 2005, Transfusion.

[63]  Edward Abraham,et al.  Transfusion-related acute lung injury: definition and review. , 2005, Critical care medicine.

[64]  C. Silliman,et al.  Transfusion-related acute lung injury. , 2005, Blood.

[65]  J. Freedman,et al.  Proceedings of a consensus conference: towards an understanding of TRALI. , 2005, Transfusion medicine reviews.

[66]  Robertson Davenport,et al.  Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel , 2004, Transfusion.

[67]  M. Nakagawa,et al.  Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion‐related acute lung injury , 2004, Transfusion.

[68]  S. Dzik,et al.  Is fresh frozen plasma overtransfused in the United States? , 2004, Transfusion.

[69]  Peter A Lachenbruch,et al.  Fatalities caused by TRALI. , 2004, Transfusion medicine reviews.

[70]  C. Chapman,et al.  Transfusion‐related acute lung injury caused by two donors with anti‐human leucocyte antigen class II antibodies: a look‐back investigation , 2004, Transfusion medicine.

[71]  L. Napolitano,et al.  Efficacy of red blood cell transfusion in the critically ill. , 2004, Critical care clinics.

[72]  M. Levy,et al.  The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States* , 2004, Critical care medicine.

[73]  W. Sibbald,et al.  Effects of storage on efficacy of red cell transfusion: When is it not safe? , 2003, Critical care medicine.

[74]  C. Chapman,et al.  Single hospital experience of TRALI , 2003, Transfusion.

[75]  C. Hack,et al.  Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis , 2003, Clinical Diagnostic Laboratory Immunology.

[76]  N. Voelkel,et al.  Plasma and lipids from stored platelets cause acute lung injury in an animal model , 2003, Transfusion.

[77]  C. Silliman,et al.  Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. , 2003, Blood.

[78]  I. Chin-Yee,et al.  Prospective audit of the use of fresh-frozen plasma, based on Canadian Medical Association transfusion guidelines. , 2002, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[79]  P. Holland,et al.  Transfusion-related acute lung injury: report of a clinical look-back investigation. , 2002, JAMA.

[80]  H. Reesink,et al.  Transfusion‐related acute lung injury (TRALI) , 2001, Vox sanguinis.

[81]  P. Holland,et al.  HLA class II antibodies in transfusion‐related acute lung injury , 2001, Transfusion.

[82]  M. Popovsky.  Transfusion and lung injury. , 2001, Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine.

[83]  J. Ernerudh,et al.  A randomized controlled trial oftransfusion‐related acute lung injury: is plasma from multiparous blood donors dangerous? , 2001, Transfusion.

[84]  D. Schoenfeld,et al.  Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.

[85]  H. Wulf,et al.  Transfusion-related lung injury with leukopenic reaction caused by fresh frozen plasma containing anti-NB1. , 1999, Anesthesiology.

[86]  E. Moore,et al.  Cardiopulmonary bypass renders patients at risk for multiple organ failure via early neutrophil priming and late neutrophil disability. , 1999, The Journal of surgical research.

[87]  G. Wells,et al.  A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. , 1999, The New England journal of medicine.

[88]  K. Yong,et al.  Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. , 1998, The Journal of infectious diseases.

[89]  N. Voelkel,et al.  Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. , 1998, The Journal of clinical investigation.

[90]  Jones,et al.  Clinical use of FFP: results of a retrospective process and outcome audit , 1998, Transfusion medicine.

[91]  H. Corwin,et al.  RBC transfusion in the ICU. Is there a reason? , 1995, Chest.

[92]  T. Carlos,et al.  Leukocyte-endothelial adhesion molecules. , 1994, Blood.

[93]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[94]  R. Henderson,et al.  Acute transfusion reactions. , 1990, The New Zealand medical journal.

[95]  A. Dalmasso,et al.  Transfusion‐related acute lung injury caused by an NB2 granulocyte‐ specific antibody in a patient with thrombotic thrombocytopenic purpura , 1990, Transfusion.

[96]  S. Moore,et al.  Diagnostic and pathogenetic considerations in transfusion‐related acute lung injury , 1985, Transfusion.

[97]  R. Yomtovian,et al.  SEVERE PULMONARY HYPERSENSITIVITY ASSOCIATED WITH PASSIVE TRANSFUSION OF A NEUTROPHIL-SPECIFIC ANTIBODY , 1984, The Lancet.

[98]  S. Moore,et al.  Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. , 2015, The American review of respiratory disease.

[99]  G. Zimmerman,et al.  Cardiovascular alterations in the adult respiratory distress syndrome. , 1982, The American journal of medicine.

[100]  E. Lester.  Letter: SI chaos. , 1976, Lancet.